These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 3590109)

  • 1. Sustained fibrinolysis after administration of t-PA despite its short half-life in the circulation.
    Eisenberg PR; Sherman LA; Tiefenbrunn AJ; Ludbrook PA; Sobel BE; Jaffe AS
    Thromb Haemost; 1987 Feb; 57(1):35-40. PubMed ID: 3109058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction.
    Lee LV; Ewald GA; McKenzie CR; Eisenberg PR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):628-33. PubMed ID: 9108774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombosis and intrinsic fibrinolysis in percutaneous transluminal angioplasty.
    Jørgensen B; Nielsen JD; Helligsø P; Baekgaard N; Egeblad M
    Eur J Vasc Surg; 1994 May; 8(3):264-9. PubMed ID: 8013675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction.
    Eisenberg PR; Sherman LA; Perez J; Jaffe AS
    Thromb Res; 1987 Apr; 46(1):109-20. PubMed ID: 3590109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early risk stratification of unstable angina/non-Q myocardial infarction: biochemical markers of coronary thrombosis.
    Galvani M; Ferrini D; Ottani F; Eisenberg PR
    Int J Cardiol; 1999 Apr; 68 Suppl 1():S55-61. PubMed ID: 10328612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.